James G. Waxmonsky, MD

  • 5Articles
  • 35KReads
  • 2010–2022Active
  • 13Collaborators
  • 65Citations

About

James G. Waxmonsky, MD, is affiliated with the Department of Psychiatry and Behavioral Health at Penn State College of Medicine in Hershey, Pennsylvania. His publications from 2010 to 2022 focus on neurodevelopmental disorders, patient care, psychiatry, and suicide. His research topics include suicidal behaviors among youth, tele-partial hospitalization programs for children and adolescents, the interaction of sex and pubertal status with ADHD and depression symptoms, and treatment effects of medications such as lisdexamfetamine dimesylate and atomoxetine in ADHD.

Publications

PCC
Suicidal Behaviors Among Youth
Original Research

Suicidal Behaviors Among Youth

July 21, 2022

In this study, the authors compared suicidal behaviors that occur during the school year with those during school break to examine demographic characteristics and comorbidities of the suicidal behaviors.
, , , et al
PCC
Original Research

Child and Adolescent Tele-Partial Hospitalization Programs in Response to COVID-19 

October 15, 2020

The COVID-19 pandemic has negatively impacted delivery of mental health services. This article describes the development and implementation of child and adolescent tele-partial hospitalization programs in response to the...
, , , et al
JCP
Original Research

Sex and Pubertal Status Moderate ADHD and Depression

May 21, 2019

Despite the high risk for depression, not all youth with attention-deficit/hyperactivity disorder develop a mood disorder. Which children are at highest risk? How does early or late puberty affect...
, ,
JCP
Original Research

Prediction of Placebo Response in 2 Clinical Trials of Lisdexamfetamine Dimesylate for the Treatment of ADHD

February 8, 2011

, , , et al
JCP
Article

Effects of Atomoxetine With and Without Behavior Therapy on the School and Home Functioning of Children With Attention-Deficit/Hyperactivity Disorder

June 29, 2010

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe